Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620488 · ClinicalTrials.gov registry record · NA
A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02620488 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 28 participants.
The verdict
NCT02620488, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This pilot study will assess the effects of a brief laboratory-based guided imagery procedure on responses to pain in patients with sickle cell disease (SCD) and healthy controls.
Interventions
- BEHAVIORAL Guided Imagery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-09 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620488
The ClinicalTrials.gov registry entry for NCT02620488 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Guided Imagery is the first listed.
NCT02620488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02620488 about?
NCT02620488 is a clinical study titled "A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease". This pilot study will assess the effects of a brief laboratory-based guided imagery procedure on responses to pain in patients with sickle cell disease (SCD) and healthy controls.
What is the current status of trial NCT02620488?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02620488?
The interventions under investigation include: Guided Imagery (BEHAVIORAL).
Who is sponsoring clinical trial NCT02620488?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.